Explore Watchlists Pricing

Astellas Pharma Inc. (4503) Balance sheet

Market cap

¥3.86T

P/E ratio

12.7x

Astellas Pharma develops, manufactures, and sells pharmaceutical products globally through a network of 77 subsidiaries across the US, Europe, and Asia.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	13,012	60,027	96,791	93,165	311,074	318,391	326,128	315,986	376,840	335,687	188,372	281,605
Marketable securities, current	-	91,530	12,024	8,000	2,000	2,607	9,459	5,560	21,297	19,784	28,784	29,941	9,572
Inventories	-	81,468	83,272	97,548	54,001	151,511	151,017	164,080	153,072	174,386	248,738	297,261	331,014
Total current assets	-	472,791	479,585	480,999	452,378	857,159	867,514	872,588	923,354	1,049,954	1,194,730	1,201,349	1,421,923
Property, plant and equipment, net	-	79,133	74,022	72,170	70,662	173,483	268,600	264,623	269,044	286,459	293,742	328,921	358,424
Marketable securities, non-current	-	68,476	51,868	29,985	33,415	81,457	74,264	95,850	91,844	97,886	108,694	106,195	138,296
Total non-current assets	-	579,991	622,577	641,832	731,268	1,040,489	1,450,646	1,401,040	1,409,041	1,406,564	2,374,873	2,138,195	2,145,119
Total assets	-	1,052,782	1,102,161	1,122,830	1,858,205	1,897,648	2,318,160	2,273,628	2,332,395	2,456,518	3,569,603	3,339,544	3,567,042
Short-term debt	-	60,677	293,643	378,070	366,583	14,136	345,707	148,163	184,964	180,131	97,565	20,144	22,342
Long-term debt, current	-	-	-	-	-	-	-	-	-	75,000	472,278	266,533	245,952
Total current liabilities	-	306,023	521,964	572,733	538,718	497,665	798,708	592,372	687,411	726,034	1,285,725	1,061,610	1,218,401
Long-term debt, non-current	-	-	-	-	-	-	-	80,000	-	189,924	553,340	671,652	409,082
Total non-current liabilities	-	5,316	29,468	35,488	32,549	141,587	230,284	295,141	184,676	222,530	687,889	764,679	517,757
Total liabilities	-	311,340	551,432	608,221	589,916	639,252	1,028,992	887,513	872,087	948,564	1,973,615	1,826,289	1,736,158
Retained earnings	-	516,511	405,042	362,061	454,719	991,957	905,851	953,289	944,261	908,158	809,400	740,939	902,836
Stockholders' equity	820,086	741,442	550,729	514,609	612,379	1,258,396	1,289,168	1,386,115	1,460,308	1,507,954	1,595,988	1,513,255	1,830,884